Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Head & Neck|February 6, 2021
Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinomaMei-Kim Ang, Jose Enrique Montoya, Ekkasit Tharavichitkul, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Head & Neck|June 24, 2014
Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinomaSiok-Hoon Ang, Benjamin Haaland, Sanchalika Acharyya, et al.
International Journal of Cancer|February 1, 2014
Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomicsDaniel S W Tan, Sophie Camilleri-Broët, Eng Huat Tan, et al.
COPD|September 1, 2021
Dysfunctional Bronchial Cilia Are a Feature of Chronic Obstructive Pulmonary Disease (COPD)Biju Thomas, Mariko Siyue Koh, Christopher O'Callaghan, et al.
Molecular Cancer|January 28, 2014
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancerDaniel S W Tan, Benjamin Haaland, Jia Min Gan, et al.
ACS Nano|February 13, 2024
High-Throughput Microfluidic Extraction of Platelet-free Plasma for MicroRNA and Extracellular Vesicle AnalysisSheng Yuan Leong, Wan Wei Lok, Kah Yee Goh, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2024
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trialLuis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, et al.
Cancers|April 26, 2020
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing ImmunotherapyWai Nam Liu, Shin Yie Fong, Wilson Wei Sheng Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2015
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancerEng Huat Tan, Daniel Shao Weng Tan, Wen Yun Li, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Head & Neck|February 6, 2021
Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinomaMei-Kim Ang, Jose Enrique Montoya, Ekkasit Tharavichitkul, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Head & Neck|June 24, 2014
Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinomaSiok-Hoon Ang, Benjamin Haaland, Sanchalika Acharyya, et al.
International Journal of Cancer|February 1, 2014
Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomicsDaniel S W Tan, Sophie Camilleri-Broët, Eng Huat Tan, et al.
COPD|September 1, 2021
Dysfunctional Bronchial Cilia Are a Feature of Chronic Obstructive Pulmonary Disease (COPD)Biju Thomas, Mariko Siyue Koh, Christopher O'Callaghan, et al.
Molecular Cancer|January 28, 2014
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancerDaniel S W Tan, Benjamin Haaland, Jia Min Gan, et al.
ACS Nano|February 13, 2024
High-Throughput Microfluidic Extraction of Platelet-free Plasma for MicroRNA and Extracellular Vesicle AnalysisSheng Yuan Leong, Wan Wei Lok, Kah Yee Goh, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2024
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trialLuis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, et al.
Cancers|April 26, 2020
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing ImmunotherapyWai Nam Liu, Shin Yie Fong, Wilson Wei Sheng Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2015
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancerEng Huat Tan, Daniel Shao Weng Tan, Wen Yun Li, et al.
Pageof 14